News

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...
See the latest Regeneron Pharmaceuticals Inc stock price (REGN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron putting up the lion's share (almost $120 million), while Illumina is ...
Review the current Regeneron Pharmaceuticals Inc (REGN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if REGN is the best investment for you.
Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its oncology pipeli ...
Check out the latest Regeneron Pharmaceuticals Inc. (REGN) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.